Search results
Results from the WOW.Com Content Network
Lorcaserin used to be approved by the Food and Drug Administration for use in the treatment of obesity before being withdrawn due to cancer risk. [72] Recombinant human leptin is very effective in those with obesity due to congenital complete leptin deficiency via decreasing energy intake and possibly increases energy expenditure. This ...
The WHO has been criticized for not stating that the COVID-19 outbreak was a pandemic until significantly after it had already clearly become one. [223] On 18 January 2021, an independent panel led by Helen Clark and Ellen Johnson Sirleaf criticised the WHO for not declaring an international emergency sooner and called for its reform. The panel ...
Death rate from obesity, 2019. Obesity is a risk factor for many chronic physical and mental illnesses.. The health effects of being overweight but not obese are controversial, with some studies showing that the mortality rate for individuals who are classified as overweight (BMI 25.0 to 29.9) may actually be lower than for those with an ideal weight (BMI 18.5 to 24.9). [1]
The CDC has found that obesity is the single strongest risk factor for severe COVID-19 illness. [51] Complications are either directly caused by obesity or indirectly related through mechanisms sharing a common cause such as a poor diet or a sedentary lifestyle. The strength of the link between obesity and specific conditions varies.
In adults with overweight/obesity, clinically significant weight loss may protect against COVID-19 [8] and neck circumference has been associated with the risk of being mechanically ventilated in COVID-19 patients, with a 26% increased risk for each centimeter increase in neck circumference. [9]
The COVID‑19 vaccines are widely credited for their role in reducing the spread of COVID‑19 and reducing the severity and death caused by COVID‑19. [ 210 ] [ 213 ] Many countries implemented phased distribution plans that prioritized those at highest risk of complications, such as the elderly, and those at high risk of exposure and ...
President Trump has touted the benefits of two drugs studied to treat COVID-19. World-renowned malaria expert Christopher Plowe, PhD, says there's not enough evidence to start prescribing it.
The COVID-19 pandemic has had many impacts on global health beyond those caused by the COVID-19 disease itself. It has led to a reduction in hospital visits for other reasons. There have been 38 per cent fewer hospital visits for heart attack symptoms in the United States and 40 per cent fewer in Spain. [1]